Publications by authors named "Maxime Karlen"

Claim this Profile
A
A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland.
Juliette Besson, Régine Audran, Maxime Karlen, Alix Miauton, Hélène Maby-El Hajjami

BMC Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study.
Alix Miauton, Régine Audran, Juliette Besson, Hélène Maby-El Hajjami, Maxime Karlen

EBioMedicine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis